At the end of the latest market close, 180 Life Sciences Corp. (ATNF) was valued at $7.08. In that particular session, Stock kicked-off at the price of $7.06 while reaching the peak value of $8.30 and lowest value recorded on the day was $6.92. The stock current value is $7.93.
Recently in News on March 26, 2021, 180 Life Sciences Corp. (NASDAQ: ATNF) Recognized R&D Pioneers in Anti-Inflammatory Therapeutics. NetworkNewsAudio – 180 Life Sciences Corp. (NASDAQ: ATNF) announces the availability of a broadcast titled, “Controlling Inflammation to Stop Disease.”. You can read further details here
Even if you’re not actively in crypto, you deserve to know what’s actually going on...
Because while leading assets such as Bitcoin (BTC) and Ethereum (ETH) are climbing in value, a select group of public “crypto stocks” are surging right along with them. More importantly, these stocks are outpacing the returns these leading crypto assets aren already producing.
Click here to get the full story… along with our long list of backdoor Bitcoin strategies. It’s free. .
180 Life Sciences Corp. had a pretty Dodgy run when it comes to the market performance. The 1-year high price for the company’s stock is recorded $10.60 on 03/26/21, with the lowest value was $2.41 for the same time period, recorded on 01/04/21.
180 Life Sciences Corp. (ATNF) full year performance was -23.90%
Price records that include history of low and high prices in the period of 52 weeks can tell a lot about the stock’s existing status and the future performance. Presently, 180 Life Sciences Corp. shares are logging -31.04% during the 52-week period from high price, and 317.37% higher than the lowest price point for the same timeframe. The stock’s price range for the 52-week period managed to maintain the performance between $1.90 and $11.50.
The company’s shares, operating in the sector of Healthcare managed to top a trading volume set approximately around 1834475 for the day, which was evidently lower, when compared to the average daily volumes of the shares.
When it comes to the year-to-date metrics, the 180 Life Sciences Corp. (ATNF) recorded performance in the market was 190.48%, having the revenues showcasing 194.80% on a quarterly basis in comparison with the same period year before. At the time of this writing, the total market value of the company is set at 187.23M, as it employees total of 2 workers.
The Analysts eye on 180 Life Sciences Corp. (ATNF)
During the last month, 0 analysts gave the 180 Life Sciences Corp. a BUY rating, 0 of the polled analysts branded the stock as an OVERWEIGHT, 0 analysts were recommending to HOLD this stock, 0 of them gave the stock UNDERWEIGHT rating, and 0 of the polled analysts provided SELL rating.
According to the data provided on Barchart.com, the moving average of the company in the 100-day period was set at 4.08, with a change in the price was noted +5.04. In a similar fashion, 180 Life Sciences Corp. posted a movement of +174.39% for the period of last 100 days, recording 1,833,207 in trading volumes.
Total Debt to Equity Ratio (D/E) can also provide valuable insight into the company’s financial health and market status. The debt to equity ratio can be calculated by dividing the present total liabilities of a company by shareholders’ equity. Debt to Equity thus makes a valuable metrics that describes the debt, company is using in order to support assets, correlating with the value of shareholders’ equity The total Debt to Equity ratio for ATNF is recording 0.55 at the time of this writing. In addition, long term Debt to Equity ratio is set at 0.00.
Technical rundown of 180 Life Sciences Corp. (ATNF)
Raw Stochastic average of 180 Life Sciences Corp. in the period of last 50 days is set at 64.16%. The result represents improvement in oppose to Raw Stochastic average for the period of the last 20 days, recording 52.57%. In the last 20 days, the company’s Stochastic %K was 47.08% and its Stochastic %D was recorded 45.62%.
Considering, the past performance of 180 Life Sciences Corp., multiple moving trends are noted. Year-to-date Price performance of the company’s stock appears to be pessimistic, given the fact the metric is recording 190.48%. Additionally, trading for the stock in the period of the last six months notably deteriorated by -28.56%, alongside a downfall of -23.90% for the period of the last 12 months. The shares increased approximately by 29.15% in the 7-day charts and went down by 86.59% in the period of the last 30 days. Common stock shares were driven by 194.80% during last recorded quarter.